Services
Expert support for evidence, access, modeling, and innovation decisions.
Pharmaeconomica helps life sciences organizations reduce uncertainty by combining HEOR, market access strategy, evidence generation, predictive modeling, and AI-enabled drug discovery expertise.
Service architecture
Not separate service lines, but one decision-science logic.
Our services are connected by one common purpose: helping clients make better decisions when evidence is incomplete, risk is high, and strategic choices matter.
Which opportunities should we prioritize?
We help assess potential value, risk, evidence maturity, biological plausibility, commercial relevance, and strategic fit.
What evidence do we need?
We identify evidence gaps and define what clinical, economic, real-world, or computational evidence is needed to support the next decision.
What is the expected value?
We support value assessment through health economic logic, scenario analysis, payer evidence thinking, and predictive modeling.
How do we plan for access?
We connect product strategy with payer expectations, HTA requirements, reimbursement pathways, and value communication.
Capabilities
Services across the life sciences value chain.
From early prioritization to access planning, Pharmaeconomica combines scientific, economic, commercial, and computational thinking.
HEOR & Health Economics
We support health economic thinking across the product lifecycle, including cost-effectiveness model planning, budget impact logic, value frameworks, evidence requirements, and economic argumentation for market access.
Cost-effectiveness and budget impact model support
Health economic strategy and model conceptualization
Evidence requirements for reimbursement and HTA
Economic value communication
Pricing & Reimbursement Strategy
We help life sciences companies understand how pricing, reimbursement, payer expectations, and evidence requirements influence commercial potential and access strategy.
Pricing and reimbursement pathway assessment
Payer evidence planning
HTA and reimbursement strategy
Access risk and opportunity assessment
Market Access Planning
We develop structured market access strategies that connect product value, evidence generation, payer needs, launch planning, and reimbursement decision-making.
Market access strategy development
Launch and pre-launch access planning
Payer value story development
Country and stakeholder-specific access planning
Evidence Generation & Literature Reviews
We synthesize scientific, clinical, economic, and real-world evidence to identify what is known, what is uncertain, and what evidence is needed to support decisions.
Targeted literature reviews
Evidence gap assessment
Clinical and economic evidence mapping
Value dossier and scientific narrative support
Predictive Modeling & Simulation
We use modeling and simulation logic to help clients evaluate uncertainty, compare scenarios, prioritize options, and support better strategic decisions.
Scenario modeling
Uncertainty and sensitivity analysis logic
Decision-support frameworks
Predictive analytics strategy
AI-Enabled Drug Discovery Strategy
We support early discovery decisions through computational thinking, predictive modeling, target-based screening logic, and PreditX-enabled candidate prioritization.
AI-enabled discovery workflow design
Target-based predictive screening strategy
ADMET and developability triage logic
Candidate prioritization and interpretation
Differentiation
Why our services fit both HEOR and early discovery.
The connection is not the service label. The connection is the method: evidence interpretation, predictive modeling, uncertainty reduction, and strategic decision support.
Work with us
Need support with evidence, access, modeling, or AI discovery strategy?
Contact Pharmaeconomica to discuss how our decision-science approach can support your project, asset, platform, or funding strategy.
info@pharmaeconomica.com